1-5 of 5
Rolf A. Brekken
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cell Competition Shapes Metastatic Latency and Relapse

Kangsan Kim, Huocong Huang, Pravat Kumar Parida, Lan He, Mauricio Marquez-Palencia, Tanner C. Reese, Payal Kapur, James Brugarolas, Rolf A. Brekken, Srinivas Malladi
Journal: Cancer Discovery
Cancer Discov (2023) 13 (1): 85–97.
https://doi.org/10.1158/2159-8290.CD-22-0236
Published: 09 January 2023
View article titled, Cell Competition Shapes Metastatic Latency and Relapse
Open the PDF for Cell Competition Shapes Metastatic Latency and Relapse in another window
Includes: Multimedia, Supplementary data
Journal Articles

MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma

Ravikanth Maddipati, Robert J. Norgard, Timour Baslan, Komal S. Rathi, Amy Zhang, Asal Saeid, Taku Higashihara, Feng Wu, Angad Kumar, Valli Annamalai, Saurav Bhattacharya, Pichai Raman, Christian A. Adkisson, Jason R. Pitarresi, Maximilian D. Wengyn, Taiji Yamazoe, Jinyang Li, David Balli, Michael J. LaRiviere, Tuong-Vi C. Ngo, Ian W. Folkert, Ian D. Millstein, Jonathan Bermeo, Erica L. Carpenter, John C. McAuliffe, Maja H. Oktay, Rolf A. Brekken, Scott W. Lowe, Christine A. Iacobuzio-Donahue, Faiyaz Notta, Ben Z. Stanger
Journal: Cancer Discovery
Cancer Discov (2022) 12 (2): 542–561.
https://doi.org/10.1158/2159-8290.CD-20-1826
Published: 01 February 2022
View article titled, <em>MYC</em> Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma
Open the PDF for <em>MYC</em> Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Faulty ECM Signaling Facilitates Autoimmune Lymphomagenesis

Rolf A. Brekken
Journal: Cancer Discovery
Cancer Discov (2014) 4 (1): 25–26.
https://doi.org/10.1158/2159-8290.CD-13-0912
Published: 07 January 2014
View article titled, Faulty ECM Signaling Facilitates Autoimmune Lymphomagenesis
Open the PDF for Faulty ECM Signaling Facilitates Autoimmune Lymphomagenesis in another window
Journal Articles

RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas

Georgia Konstantinidou, Giorgio Ramadori, Francesca Torti, Kim Kangasniemi, Rachel E. Ramirez, Yiran Cai, Carmen Behrens, Michael T. Dellinger, Rolf A. Brekken, Ignacio I. Wistuba, Adriana Heguy, Julie Teruya-Feldstein, Pier Paolo Scaglioni
Journal: Cancer Discovery
Cancer Discov (2013) 3 (4): 444–457.
https://doi.org/10.1158/2159-8290.CD-12-0388
Published: 10 April 2013
View article titled, RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas
Open the PDF for RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas in another window
Includes: Supplementary data
Journal Articles

Anti-VEGF Therapy Revived by c-Met Inhibition, but Is c-Met the Answer?

Kristi D. Lynn, Rolf A. Brekken
Journal: Cancer Discovery
Cancer Discov (2012) 2 (3): 211–213.
https://doi.org/10.1158/2159-8290.CD-12-0037
Published: 13 March 2012
View article titled, Anti-VEGF Therapy Revived by c-Met Inhibition, but Is c-Met the Answer?
Open the PDF for Anti-VEGF Therapy Revived by c-Met Inhibition, but Is c-Met the Answer? in another window